Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

2ccPA

Next Previous
Drug Profile

2ccPA

Alternative Names: 2-carba-cyclic phosphatidic acid - Orient Europharma; Cyclic phosphatidic acid derivative - Orient Europharma

Latest Information Update: 14 Apr 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Orient Europharma
  • Class Analgesics; Anti-inflammatories; Antirheumatics; Phosphatidic acids
  • Mechanism of Action ENPP2 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Osteoarthritis

Most Recent Events

  • 03 Nov 2022 Phase-I/II clinical trials in Osteoarthritis (In the elderly, In adults) in Taiwan (Intra-articular) (NCT05807529)
  • 28 Aug 2021 No recent reports of development identified for phase-I development in Osteoarthritis(In the elderly, In adults) in Taiwan (Intra-articular, Injection)
  • 22 Mar 2021 Orient Europharma completes a phase I trial in Osteoarthritis (In adults, In the elderly) in Taiwan (Intra-articular) (NCT04229394)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top